AVONEX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug AVONEX contains one active pharmaceutical ingredient (API):

1 Interferon beta-1a UNII XRO4566Q4R - INTERFERON BETA-1A

Interferon beta-1a exerts its biological effects by binding to specific receptors on the surface of human cells. This binding initiates a complex cascade of intracellular events that leads to the expression of numerous interferon-induced gene products and markers. Whether the mechanism of action of interferon beta-1a in MS is mediated by the same pathway as the biological effects described above is not known because the pathophysiology of MS is not well established. Read about Interferon beta-1a

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AVONEX Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AB07	Interferon beta-1a	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8805K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538300102150413
Country: CA	Health Products and Food Branch	Identifier(s): 02269201
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28726-02-09
Country: EE	Ravimiamet	Identifier(s): 1036369, 1212893, 1299944, 1591286, 1591297
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 97033005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 017234, 412547
Country: FR	Base de données publique des médicaments	Identifier(s): 62493653, 66674494
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 140717, 193768, 195627, 51844
Country: HK	Department of Health Drug Office	Identifier(s): 62261
Country: IE	Health Products Regulatory Authority	Identifier(s): 88251, 88285, 88286
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7370
Country: JP	医薬品医療機器総合機構	Identifier(s): 6399422G1027, 6399422G2023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004450, 1005046, 1015687, 1063637, 1063638
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106356, 71021
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11066, 14931, 7717
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100092430, 100127111
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65147001, W65147002, W65231001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10913012H, 10913013H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699783950033
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/34/0743, A40/34/0502